This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veterinary Autologous Cell-based Therapy Development
In veterinary cell therapy, living cells with specific functions are obtained from diseased animals or external sources and then reinfused after in vitro manipulation to treat animal diseases. Autologous cell therapy, an important aspect of veterinary cell therapy, is categorized by cell source. It involves activating and amplifying the diseased individual's own cells in vitro, producing highly efficient and low-toxicity functional cells, and reinfusing them into the animal to treat the disease. BioVenic help develop successful veterinary autologous cell therapies using its advanced technology platform for in vitro manipulation of animal cells. Our skilled technical team excels in various in vitro operations such as cell separation, purification, culture, amplification, activation, cell line establishment, cryopreservation and release, ensuring an efficient and reliable veterinary autologous cell-based therapy development process.
To learn more about our custom animal cell solutions, please visit:
Fig.1 Veterinary Cell Therapy Development.
BioVenic focuses on the development of autologous cell therapies for animals. By manipulating, expanding, processing and re-implanting cells, we are creating innovative solutions for the treatment of incurable and degenerative diseases in companion animals and livestock. Autologous cells are less likely to cause complications due to immune rejection and are easier to use than other regenerative medicine technologies.
Autologous Stem Cell Therapy Development
BioVenic provides clients with a full range of technical services and innovative engineering for the advancement of autologous stem cell therapy. Stem cell therapy is widely used in veterinary regenerative medicine to treat musculoskeletal and skin diseases. The use of mesenchymal stem cells and induced pluripotent stem cells in cell therapy allows stem cells to differentiate into various cell types for therapeutic purposes. We have an exclusive research platform dedicated to animal stem cells that facilitates the efficient completion of key technical processes such as in vitro stem cell survival, maintenance and directed differentiation. This ensures the seamless advancement of therapeutic development.
Autologous CAR-T Therapy Development
CAR T-cell therapy is a personalized technology based on animal immune cells. CAR T cells are generated from immune cells harvested from individual diseased animals. The collected T cells are genetically modified in the laboratory to produce special receptors called chimeric antigen receptors (CARs). BioVenic helps in developing autologous CAR-T therapy for animals and is committed to achieving targeted improvements in T-cell viability, survival, proliferation and engraftment. We excel in various biotechnologies related to cell transfection and in vitro culture. We can seamlessly insert CAR sequences into the T cell genome, enabling T cells to specifically recognize and bind to tumor cells and subsequently kill them by releasing factors such as perforin. We are committed to being your competent scientific research partner in the development of this promising therapy for the treatment of tumors in animals.
Applications of Autologous Cell Therapy for Veterinary Use
| Field | Applications |
| Tumor Treatment |
|
| Veterinary Regenerative Therapy |
|
| Degenerative Disease Treatment |
|
Why Choose Us?
Integrated Animal Cell Research Platform
BioVenic offers comprehensive technical services related to animal and stem cells, including separation, culture, differentiation and transformation.
Professional Veterinary Cell Therapy Development
BioVenic has established a specialized team of cutting-edge veterinary cell therapy experts to ensure smooth and efficient development of animal therapy research, from design to implementation.
Full Coverage of Veterinary Cell Therapy Study
BioVenic specializes in tailoring scientific research plans and developing programs for various types of veterinary cell therapy for clients. Our services are not limited to autologous cell therapy, but offer full coverage and personalized attention.
BioVenic continues to focus on the rapidly evolving field of veterinary cell therapy. We combine a proprietary comprehensive animal cell and stem cell technology platform to provide a one-stop solution for researchers worldwide developing autologous cell therapy for animals. Our extensive project experience and mature animal cell technology system ensure the scientific rigor of each basic research and therapy development process. If you are interested in veterinary cell therapy and considering related research projects, please do not hesitate to contact us.